Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck

NCT00513383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck

Interventions

DRUG: Panitumumab
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: Intensity Modulated Radiation Therapy
DRUG: 5-Fluorouracil
DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]